Product Information
QC MIGRAINE 250-250-65 MG CPLT is a generic product labeled by Chain Drug Marketing Association, priced at $0.0672 per EA under NDC 83324009924. Its NADAC has been published 69 times since Jan 29, 2025.
Strength
250; 250; 65 mg/1; mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324009924
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
ACETAMINOPHEN; ASPIRIN; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA214039On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for QC MIGRAINE 250-250-65 MG CPLT has been published 69 times since Jan 29, 2025, and over the history we have for it it has risen 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0672 per EA |
|---|---|
| All-time high | $0.0691 (Oct 15, 2025) |
| All-time low | $0.0628 (Jan 29, 2025) |
| 52-week high | $0.0691 |
| 52-week low | $0.0635 |
| Median price | $0.0656 |
| Average price | $0.0657 |
| Largest weekly change | +5.5% (Apr 23, 2025) |
| Weeks tracked | 69 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ACETAMINOPHEN, ASPIRIN and CAFFEINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QC MIGRAINE 250-250-65 MG CPLT?
The current National Average Drug Acquisition Cost (NADAC) for QC MIGRAINE 250-250-65 MG CPLT, manufactured by Chain Drug Marketing Association, is $0.0672 per EA (NDC 83324009924), effective May 20, 2026.
How has the price of QC MIGRAINE 250-250-65 MG CPLT changed over time?
Over the history we have for it, the NADAC for QC MIGRAINE 250-250-65 MG CPLT has risen 6.9%. It has been tracked across 69 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for QC MIGRAINE 250-250-65 MG CPLT?
Since Jan 29, 2025, the NADAC for QC MIGRAINE 250-250-65 MG CPLT has ranged from a low of $0.0628 (Jan 29, 2025) to a high of $0.0691 (Oct 15, 2025), with a median of $0.0656 per EA.
Are there cheaper alternatives to QC MIGRAINE 250-250-65 MG CPLT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QC MIGRAINE 250-250-65 MG CPLT, so no direct lower-cost alternative is listed.
Who manufactures QC MIGRAINE 250-250-65 MG CPLT?
QC MIGRAINE 250-250-65 MG CPLT (NDC 83324009924) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification